Mereo BioPharma Group Plc (MREO)
0.305
0.00 (0.00%)
USD |
NASDAQ |
Nov 12, 16:00
0.305
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Price to Book Value : 2.054 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.054 |
| November 11, 2026 | 2.065 |
| November 10, 2026 | 2.006 |
| November 09, 2026 | 1.988 |
| November 06, 2026 | 1.906 |
| November 05, 2026 | 1.888 |
| November 04, 2026 | 2.041 |
| November 03, 2026 | 1.960 |
| November 02, 2026 | 1.953 |
| October 30, 2026 | 1.950 |
| October 29, 2026 | 2.033 |
| October 28, 2026 | 2.000 |
| October 27, 2026 | 1.965 |
| October 26, 2026 | 1.852 |
| October 23, 2026 | 1.897 |
| October 22, 2026 | 1.936 |
| October 21, 2026 | 1.961 |
| October 20, 2026 | 1.988 |
| October 19, 2026 | 2.035 |
| October 16, 2026 | 2.041 |
| October 15, 2026 | 2.082 |
| October 14, 2026 | 2.084 |
| October 13, 2026 | 2.155 |
| October 12, 2026 | 2.123 |
| October 09, 2026 | 2.356 |
| Date | Value |
|---|---|
| October 08, 2026 | 2.527 |
| October 07, 2026 | 2.376 |
| October 06, 2026 | 2.358 |
| October 05, 2026 | 2.613 |
| October 02, 2026 | 2.558 |
| October 01, 2026 | 2.471 |
| September 30, 2026 | 2.707 |
| September 29, 2026 | 2.079 |
| September 28, 2026 | 2.061 |
| September 25, 2026 | 2.061 |
| September 24, 2026 | 1.880 |
| September 23, 2026 | 1.896 |
| September 22, 2026 | 1.762 |
| September 21, 2026 | 1.616 |
| September 18, 2026 | 1.688 |
| September 17, 2026 | 1.616 |
| September 16, 2026 | 1.482 |
| September 15, 2026 | 1.588 |
| September 14, 2026 | 1.560 |
| September 11, 2026 | 1.560 |
| September 10, 2026 | 1.363 |
| September 09, 2026 | 1.351 |
| September 08, 2026 | 1.418 |
| September 04, 2026 | 1.393 |
| September 03, 2026 | 1.516 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 24.80 |
| BioNTech SE | 1.048 |
| Silence Therapeutics Plc | 24.05 |
| Autolus Therapeutics Plc | 15.43 |
Price to Book Value Related Metrics
| PS Ratio | 61.14 |
| Price | 0.305 |
| Earnings Yield | -55.08% |
| Market Cap | 48.71M |